On 3 November 2017, the Dutch Supreme Court (Hoge Raad) handed down a landmark decision on the infringement of second medical use patents in the Merck Sharp & Dohme Corp. (“MSD”) v. Teva Pharma B.V. and Pharmachemie B.V....more
11/13/2017
/ Direct Infringement ,
Generic Drugs ,
Intellectual Property Protection ,
Merck ,
Netherlands ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Swiss Style Claims ,
Teva Pharmaceuticals